Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages

Ulcerative colitis (UC) is characterized by a functional dysregulation of alternatively activated macrophage (AAM) and intestinal epithelial cells (IECs) homeostasis. Chromogranin-A (CHGA) secreted by neuroendocrine cells is implicated in intestinal inflammation and immune dysregulation. CHGA underg...

Full description

Bibliographic Details
Main Authors: Nour Eissa, Hayam Hussein, Laëtitia Kermarrec, Jasmine Grover, Marie-Hélène Et Metz-Boutigue, Charles N. Bernstein, Jean-Eric Ghia
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.01131/full
_version_ 1811318547309133824
author Nour Eissa
Nour Eissa
Hayam Hussein
Laëtitia Kermarrec
Jasmine Grover
Marie-Hélène Et Metz-Boutigue
Charles N. Bernstein
Charles N. Bernstein
Jean-Eric Ghia
Jean-Eric Ghia
Jean-Eric Ghia
Jean-Eric Ghia
author_facet Nour Eissa
Nour Eissa
Hayam Hussein
Laëtitia Kermarrec
Jasmine Grover
Marie-Hélène Et Metz-Boutigue
Charles N. Bernstein
Charles N. Bernstein
Jean-Eric Ghia
Jean-Eric Ghia
Jean-Eric Ghia
Jean-Eric Ghia
author_sort Nour Eissa
collection DOAJ
description Ulcerative colitis (UC) is characterized by a functional dysregulation of alternatively activated macrophage (AAM) and intestinal epithelial cells (IECs) homeostasis. Chromogranin-A (CHGA) secreted by neuroendocrine cells is implicated in intestinal inflammation and immune dysregulation. CHGA undergoes proteolytic processing to generate CHGA-derived peptides. Chromofungin (CHR: CHGA47–66) is a short CHGA-derived peptide encoded by CHGA Exon-IV and is involved in innate immune regulation, but the basis is poorly investigated. We investigated the expression of CHR in colonic tissue of patients with active UC and assessed the effects of the CHR in dextran sulfate sodium (DSS) colitis in mice and on macrophages and human colonic epithelial cells. We found that mRNA expression of CHR correlated positively with mRNA levels of AAM markers and gene expression of tight junction (TJ) proteins and negatively with mRNA levels of interleukin (IL)-8, IL-18, and collagen in patients with active UC. Moreover, AAM markers correlated positively with gene expression of TJ proteins and negatively with IL-8, IL-18, and collagen gene expression. Experimentally, intracolonic administration of CHR protected against DSS-induced colitis by priming macrophages into AAM, reducing colonic collagen deposition, and maintaining IECs homeostasis. This effect was associated with a significant increase of AAM markers, reduction of colonic IL-18 release and conservation of gene expression of TJ proteins. In vitro, CHR enhanced AAM polarization and increased the production of anti-inflammatory mediators. CHR-treated AAM conditioned medium increased Caco-2 cell migration, viability, proliferation, and mRNA levels of TJ proteins, and decreased oxidative stress-induced apoptosis and proinflammatory cytokines release. Direct CHR treatments had the same effect. In conclusion, CHR treatment reduces the severity of colitis and the inflammatory process via enhancing AAM functions and maintaining IECs homeostasis. CHR is involved in the pathogenesis of inflammation in experimental colitis. These findings provide insight into the mechanisms of colonic inflammation and could lead to new therapeutic strategies for UC.
first_indexed 2024-04-13T12:27:47Z
format Article
id doaj.art-365d092769404b44a8492d1bd40ff77a
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T12:27:47Z
publishDate 2017-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-365d092769404b44a8492d1bd40ff77a2022-12-22T02:46:58ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-09-01810.3389/fimmu.2017.01131291143Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated MacrophagesNour Eissa0Nour Eissa1Hayam Hussein2Laëtitia Kermarrec3Jasmine Grover4Marie-Hélène Et Metz-Boutigue5Charles N. Bernstein6Charles N. Bernstein7Jean-Eric Ghia8Jean-Eric Ghia9Jean-Eric Ghia10Jean-Eric Ghia11Immunology Department, University of Manitoba, Winnipeg, MB, CanadaChildren’s Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB, CanadaDepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Ohio State University, Columbus, OH, United StatesImmunology Department, University of Manitoba, Winnipeg, MB, CanadaImmunology Department, University of Manitoba, Winnipeg, MB, CanadaINSERM U977, Biomatériaux et Ingéniérie tissulaire, Institut Leriche 2éme étage, Hôpital Civil, Porte de l’Hôpital, Strasbourg, FranceRady Faculty of Health Sciences, Department of Internal Medicine, Section of Gastroenterology, University of Manitoba, Winnipeg, MB, CanadaUniversity of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, CanadaImmunology Department, University of Manitoba, Winnipeg, MB, CanadaChildren’s Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB, CanadaRady Faculty of Health Sciences, Department of Internal Medicine, Section of Gastroenterology, University of Manitoba, Winnipeg, MB, CanadaUniversity of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, CanadaUlcerative colitis (UC) is characterized by a functional dysregulation of alternatively activated macrophage (AAM) and intestinal epithelial cells (IECs) homeostasis. Chromogranin-A (CHGA) secreted by neuroendocrine cells is implicated in intestinal inflammation and immune dysregulation. CHGA undergoes proteolytic processing to generate CHGA-derived peptides. Chromofungin (CHR: CHGA47–66) is a short CHGA-derived peptide encoded by CHGA Exon-IV and is involved in innate immune regulation, but the basis is poorly investigated. We investigated the expression of CHR in colonic tissue of patients with active UC and assessed the effects of the CHR in dextran sulfate sodium (DSS) colitis in mice and on macrophages and human colonic epithelial cells. We found that mRNA expression of CHR correlated positively with mRNA levels of AAM markers and gene expression of tight junction (TJ) proteins and negatively with mRNA levels of interleukin (IL)-8, IL-18, and collagen in patients with active UC. Moreover, AAM markers correlated positively with gene expression of TJ proteins and negatively with IL-8, IL-18, and collagen gene expression. Experimentally, intracolonic administration of CHR protected against DSS-induced colitis by priming macrophages into AAM, reducing colonic collagen deposition, and maintaining IECs homeostasis. This effect was associated with a significant increase of AAM markers, reduction of colonic IL-18 release and conservation of gene expression of TJ proteins. In vitro, CHR enhanced AAM polarization and increased the production of anti-inflammatory mediators. CHR-treated AAM conditioned medium increased Caco-2 cell migration, viability, proliferation, and mRNA levels of TJ proteins, and decreased oxidative stress-induced apoptosis and proinflammatory cytokines release. Direct CHR treatments had the same effect. In conclusion, CHR treatment reduces the severity of colitis and the inflammatory process via enhancing AAM functions and maintaining IECs homeostasis. CHR is involved in the pathogenesis of inflammation in experimental colitis. These findings provide insight into the mechanisms of colonic inflammation and could lead to new therapeutic strategies for UC.http://journal.frontiersin.org/article/10.3389/fimmu.2017.01131/fullchromogranin-Agut-derived peptidesoxidative stressmucosal drug actionepithelial homeostasismacrophages switch
spellingShingle Nour Eissa
Nour Eissa
Hayam Hussein
Laëtitia Kermarrec
Jasmine Grover
Marie-Hélène Et Metz-Boutigue
Charles N. Bernstein
Charles N. Bernstein
Jean-Eric Ghia
Jean-Eric Ghia
Jean-Eric Ghia
Jean-Eric Ghia
Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages
Frontiers in Immunology
chromogranin-A
gut-derived peptides
oxidative stress
mucosal drug action
epithelial homeostasis
macrophages switch
title Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages
title_full Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages
title_fullStr Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages
title_full_unstemmed Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages
title_short Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages
title_sort chromofungin ameliorates the progression of colitis by regulating alternatively activated macrophages
topic chromogranin-A
gut-derived peptides
oxidative stress
mucosal drug action
epithelial homeostasis
macrophages switch
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.01131/full
work_keys_str_mv AT noureissa chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT noureissa chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT hayamhussein chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT laetitiakermarrec chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT jasminegrover chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT marieheleneetmetzboutigue chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT charlesnbernstein chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT charlesnbernstein chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT jeanericghia chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT jeanericghia chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT jeanericghia chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages
AT jeanericghia chromofunginamelioratestheprogressionofcolitisbyregulatingalternativelyactivatedmacrophages